KOD
Kodiak Sciences Inc
NASDAQ: KOD · HEALTHCARE · BIOTECHNOLOGY
$43.48
-0.44% today
Updated 2026-04-30
Market cap
$2.71B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$3 – $48
Volume
1.2M
Kodiak Sciences Inc (KOD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-149.50%
ROA
-42.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $0.00 | $-17.13M | — | — | — |
| 2017 | $0.00 | $-27.94M | — | — | — |
| 2018 | $0.00 | $-41.44M | — | — | — |
| 2019 | $0.00 | $-47.37M | — | — | — |
| 2020 | $0.00 | $-133.10M | — | — | — |
| 2021 | $0.00 | $-266.99M | — | — | — |
| 2022 | $0.00 | $-333.82M | — | — | — |
| 2023 | $0.00 | $-260.49M | — | — | — |
| 2024 | $0.00 | $-176.21M | — | — | — |
| 2025 | $0.00 | $-229.97M | — | — | — |